Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Revenue projections:

COO's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio	1.222000
forwardPE	12.394219
debtToEquity	33.634000
earningsGrowth	3.571000
revenueGrowth	0.006000
grossMargins	0.659280
operatingMargins	0.208220
trailingEps	2.910000
forwardEps	4.692510

COO's current ratio of 1.222, indicating that the company can meet its short-term debt obligations with ease. This high liquidity level is a positive sign, as COO has enough cash and current assets to handle its immediate liabilities comfortably.
COO's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
The Cooper Companies, Inc.'s positive gross and operating margins suggest that the company is operating profitably. These strong margins indicate effective cost management and revenue generation, contributing to a solid financial foundation.
COO's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that COO's financial performance will improve in the current financial year.

Price projections:

Over time, The Cooper Companies, Inc.'s price projections have consistently been revised lower. This downward shift suggests analysts are becoming more cautious about the company's future, possibly due to emerging risks or challenges.

Insider Transactions:

There were 10 buy transactions of COO, with market price at 69.36499977111816.No buy transactions took place in the period under consideration.The higher volume of sells at The Cooper Companies, Inc.'s current price levels could indicate potential for further price drops. If this selling trend continues, investors might expect the stock's value to decline as more shareholders exit their positions.

Recommendation changes over time:

A recent buy bias from analysts toward COO may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that COO might be an appealing option for those looking to grow their wealth through stock market investments.